Clinical trial NCT03580538: Training With Elastic Tubing in Cardiopaths: Clinical Trial
Official title: The Short-term Effects of a Resistive Training Program Using Elastic Tubing in Cardiac Patients: Clinical Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Resistance Training
Muscular Strength
Cardiovascular Diseases
Lead sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho
Sponsor class: OTHER
First posted: 2018-07-09
Enrollment: 13
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Background: Resistance training is effective in cardiac rehabilitation; however, other types of training, such as elastic tubing, are rarely used and may present good therapeutic alternatives. Due to its practicality and cost effectiveness, training using elastic tubing may become an important tool in cardiovascular rehabilitation. Objective: To evaluate muscular strength, functional capacity, aerobic capacity and quality of life in patients with cardiovascular diseases in phase II of rehabilitation, after resistance training with elastic tubing. Methods: patients with cardiovascular diseases performed training with elastic tubing for six weeks, twice a week and the load was progressively increased every 15 days. The following muscle groups were evaluated and trained: shoulder abductors and flexors, elbow flexors, and knee flexors and extensors. Muscular strength was evaluated using a dynamometer; functional capacity with a 6-minute walk test and ergospirometric test; and quality of life using the SF-36 questionnaire. Data normality was assessed using the Shapiro Wilk test. Comparisons before and after training were performed using the paired Student's t test or the Wilcoxon test (p \<5%).


Eligibility criteria: Inclusion Criteria:

* Patients of both sexes
* Aged between 45-79 years
* Clinical diagnosis of heart disease (coronary artery disease, postoperative myocardial revascularization, acute myocardial infarction)
* In phase II of CRP for at least three months

Exclusion Criteria:

* Patients hemodynamically unstable
* Patients with changes in medication for a minimum of 30 days
* Patients who presented arteriopathies, neurological, muscular or orthopedic disorders, such as rheumatism and unstable heart disease that could be detected by electrocardiogram, and lung diseases.

Primary outcomes:
measure: Change from baseline Muscular Strength at 6 weeks
timeFrame: The evaluation of muscular strength was performed at the start of the intervention protocol and after 6 weeks.
measure: Change from baseline Functional Capacity at 6 weeks
timeFrame: was performed at the start of the intervention protocol and after 6 weeks
measure: Change from baseline Evaluation of maximal aerobic capacity at 6 weeks
timeFrame: was performed at the start of the intervention protocol and after 6 weeks
measure: Change from baseline Evaluation of quality of life at 6 weeks
timeFrame: was performed at the start of the intervention protocol and after 6 weeks
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References: